$RXMD is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year.
During the Earnings Call held on November 14, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. In addition to record breaking sales, the company has been successful in its efforts to upgrade its OTCMarkets listing tier to OTCQB. The sales reported are recognized from diversified revenue streams and ongoing development of the Company’s portfolio of healthcare services. Innovation is also a factor as the company launched numerous new and exciting programs in 2017, such as its tele-pharmacy platform.
“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”